These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8597170)

  • 1. Chemical structure--teratogenicity relationships, toxicokinetics and metabolism in risk assessment of retinoids.
    Nau H
    Toxicol Lett; 1995 Dec; 82-83():975-9. PubMed ID: 8597170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of metabolism and toxicokinetics in retinoid teratogenesis.
    Tzimas G; Nau H
    Curr Pharm Des; 2001 Jun; 7(9):803-31. PubMed ID: 11375780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratology of retinoids.
    Collins MD; Mao GE
    Annu Rev Pharmacol Toxicol; 1999; 39():399-430. PubMed ID: 10331090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
    Arafa HM; Elmazar MM; Hamada FM; Reichert U; Shroot B; Nau H
    Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of retinoids in developmental toxicology. IV. Planar Cisoid conformational restriction.
    Willhite CC; Dawson MI
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):324-44. PubMed ID: 2330592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy.
    Nau H; Tzimas G; Mondry M; Plum C; Spohr HL
    Life Sci; 1995; 57(1):53-60. PubMed ID: 7596221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
    Nau H
    J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC; Lovey A; Eckhoff C
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of retinoids in developmental toxicology. II. Influence of the polyene chain of the vitamin A molecule.
    Willhite CC
    Toxicol Appl Pharmacol; 1986 May; 83(3):563-75. PubMed ID: 3705076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity and dose-response relationships in the neural and behavioral teratogenesis of retinoids.
    Adams J
    Neurotoxicol Teratol; 1993; 15(3):193-202. PubMed ID: 8336680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.
    Kraft JC; Kochhar DM; Scott WJ; Nau H
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):474-82. PubMed ID: 3470977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of retinoids in developmental toxicology. III. Contribution of the vitamin A beta-cyclogeranylidene ring.
    Howard WB; Willhite CC; Dawson MI; Sharma RP
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):122-38. PubMed ID: 3413791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished teratogenicity of retinoid X receptor-selective synthetic retinoids.
    Jiang H; Penner JD; Beard RL; Chandraratna RA; Kochhar DM
    Biochem Pharmacol; 1995 Aug; 50(5):669-76. PubMed ID: 7669070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
    Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
    Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplacental pharmacokinetics of a synthetic retinoid which is not bound by mouse embryonic cellular retinoic acid-binding protein.
    Sass JO; Hartmann J; Chahoud I; Shroot B; Nau H
    Toxicol Lett; 1995 Jan; 75(1-3):159-68. PubMed ID: 7863522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratogenicity, tissue distribution, and metabolism of the retro-retinoids, 14-hydroxy-4,14-retro-retinol and anhydroretinol, in the C57BL/6J mouse.
    Mao GE; Collins MD; Derguini F
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):38-49. PubMed ID: 10662603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-affinity relationships of retinoids with embryonic cellular retinoic acid-binding protein.
    Willhite CC; Jurek A; Sharma RP; Dawson MI
    Toxicol Appl Pharmacol; 1992 Jan; 112(1):144-53. PubMed ID: 1310166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
    Soprano DR; Tairis N; Gyda M; Harnish DC; Jiang H; Soprano KJ; Kochhar DM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.